BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2469102)

  • 1. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
    Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
    Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
    J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
    Lerner RW; Lopaschuk GD; Catena RC; Olley PM
    Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
    Li SR; Yang Q; Wandl E; Pirker W; Virgolini I
    Br J Cancer; 1993 Oct; 68(4):695-701. PubMed ID: 7691143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL; Andersen NH; Robertson RP
    J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandin interaction in the human liver].
    Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
    Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of prostaglandin I2 binding sites in thyroid cancer.
    Virgolini I; Hermann M; Sinzinger H
    Br J Cancer; 1988 Nov; 58(5):584-8. PubMed ID: 2464364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization and autoradiographic localization of [3H]PGE2 binding sites in rat kidney.
    Eriksson LO; Larsson B; Andersson KE
    Acta Physiol Scand; 1990 Jul; 139(3):405-15. PubMed ID: 2173351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
    Sharif NA; Davis TL
    J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
    Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
    Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin E1 on low density lipoprotein apo-B-receptor binding in human, rat and swine liver in vitro.
    Virgolini I; Li SR; Lupattelli G; Pidlich J; Angelberger P; Banyai M; Sinzinger H
    Prostaglandins; 1991 Jul; 42(1):81-93. PubMed ID: 1663256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific prostaglandin E2 binding sites in isolated rat glomeruli: evidence for glomerular PGE receptors.
    Chaudhari A; Kirschenbaum MA
    Prostaglandins Leukot Med; 1985 Oct; 20(1):55-68. PubMed ID: 2866541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
    Eriksson LO; Larsson B; Hedlund H; Andersson KE
    Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment and characterization of specific [3H]PGE2 binding sites in the porcine gastric mucosa.
    Beinborn M; Netz S; Staar U; Sewing KF
    Eur J Pharmacol; 1988 Mar; 147(2):217-26. PubMed ID: 2452750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity prostaglandin E receptors attenuate adenylyl cyclase activity in isolated bovine myometrial membrane.
    Lerner RW; Lopaschuk GD; Olley PM
    Can J Physiol Pharmacol; 1990 Dec; 68(12):1574-80. PubMed ID: 1964864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 receptor of rat submandibular salivary glands.
    Wu-Wang CY; Wang SL; Yao P; Slomiany A; Slomiany BL
    Arch Oral Biol; 1991; 36(9):637-40. PubMed ID: 1741694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.